Acetazolamide Market
- 2026 年市場規模
- USD 279 Mn
- 2033 年預估規模
- USD 387.6 Mn
- 年複合成長率 CAGR
- 4.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Acetazolamide Market, By Formulation (Tablets, Capsules and Injection), By Application (Glaucoma, Epilepsy, Drug-induced Edema, Altitude Sickness, Fluid Retention, Heart Failure and Seizures), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
Acetazolamide is an enzyme inhibitor, which acts specifically on carbonic anhydrase. Acetazolamide, sold under the trade name Diamox, is used to treat glaucoma, altitude sickness, epilepsy, fluid retention, heart failure, and seizures.
In addition to this, acetazolamide (carbonic anhydrase inhibitor) is effective in controlling fluid secretions, to treat certain convulsive disorders, and promotes diuresis in instances of abnormal fluid retention such as cardiac edema.
Increasing effectiveness of acetazolamide in treating other indication such as drug induced edema and brain tumor glioblastoma is offering growth prospective for key drug manufacturers in this market. For instance, according to a new study published in Science Translational Medicine Journal in July 2018, acetazolamide may also be effective in treating glioblastoma, fast-growing brain tumor. As per the study findings, acetazolamide can restore temozolomide’s (TMZ) ability to kill tumor cells. Furthermore, the study suggested that the combination of acetazolamide with TMZ may be an effective subgroup to consider for trial for patients with high BCL-3 expression.
Market Dynamics
Increasing prevalence of glaucoma and its risk factors among global population is propelling demand for acetazolamide during the forecast period. Moreover, acetazolamide is commonly used for preventing high altitude illness, this increases the utility of the drug.
For instance, according to the International Journal of Advanced Medical and Health Research, 2015, glaucoma is seen to be the second major reason causing blindness among people across the world, followed by cataract.
Furthermore, according to the BrightFocus Foundation, June 2017 data findings, over 3 million Americans suffer from glaucoma, out of which 2.7 million (aged 40 and older) are affected by its most common form, open-angle glaucoma. Also, high prevalence of eye disorder in the geriatric population and nutritional deficiency in the younger population due to changing food habits are other factors affecting the health of the people globally, which might lead to boost growth of acetazolamide market. Acetazolamide capsule taken once a day by patients with chronic glaucoma offers a substantial pressure-lowering effect, which lasts at least 23 hours.
Acetazolamide helps in preventing acute mountain sickness and has fewer side effects than alternative drugs such as dexamethasone, which can mask symptoms and therefore carries greater risk.
Key features of the study
• This report provides in-depth analysis of acetazolamide market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, drug approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global acetazolamide market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as part of this study include Teva Pharmaceutical Industries Ltd., Accord Healthcare Ltd. (Intas Pharmaceuticals Limited), Heritage Pharmaceuticals Inc., Nostrum Laboratories Inc., Novast Laboratories Ltd., Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.), Lannett Company, Inc., Strides Shasun Limited, and X-GEN Pharmaceuticals, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future drug launch, manufacturing up-gradation, market expansion, and marketing tactics
• The global acetazolamide market report caters to various stakeholders in this industry including investors, suppliers, acetazolamide based product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the acetazolamide market.
Market Segmentation
• By Formulation Insights (Revenue, US$ Mn, 2021 - 2033)
o Tablets
o Capsules
o Injection
• By Application Insights (Revenue, US$ Mn, 2021 - 2033)
o Glaucoma
o Epilepsy
o Drug-induced Edema
o Altitude Sickness
o Fluid Retention
o Heart Failure and Seizures
• By Distribution Channel Insights (Revenue, US$ Mn, 2021 - 2033)
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
• By Region Insights (Revenue, US$ Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players in the Acetazolamide Market
o Teva Pharmaceutical Industries Ltd.
o Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
o Heritage Pharmaceuticals Inc.
o Nostrum Laboratories Inc.
o Novast Laboratories Ltd.
o Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.)
o Lannett Company, Inc.
o Strides Shasun Limited
o X-GEN Pharmaceuticals, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Formulation
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Epidemiology
o Key Developments
o Drug Approvals and Launches
o Strategic Collaborations & Acquisitions
o Regulatory Scenario
o Pipeline Analysis
4. Global Acetazolamide Market, By Formulation, 2021 - 2033, (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
5. Global Acetazolamide Market, By Application, 2021 - 2033, (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Glaucoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Epilepsy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Drug indicted Edema
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Altitude Sickness
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Fluid Retention
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Heart Failure
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Seizures
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
6. Global Acetazolamide Market, By Distribution Channel, 2021 - 2033, (US$ Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
o Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
7. Global Acetazolamide Market, By Region, 2021 - 2033, (US$ Million)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022 - 2033
o North America
Market Size and Forecast, By Formulation, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Formulation, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Formulation, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Formulation, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Formulation, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
o North Africa
o Central Africa
o South Africa
o Middle East
Market Size and Forecast, By Formulation, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Application, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, (US$ Million)
Market Size and Forecast, By Country, 2021 - 2033, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Teva Pharmaceutical Industries Ltd.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
Accord Healthcare Ltd. (Intas Pharmaceuticals Limited)
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
Heritage Pharmaceuticals Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
Nostrum Laboratories Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
Novast Laboratories Ltd.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
Cadila Healthcare (Zydus Pharmaceuticals (USA) Inc.)
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
Lannett Company, Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
Strides Shasun Limited
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
X-GEN Pharmaceuticals, Inc.
o Company Overview
o Drug Portfolio
o Financial Performance
o Recent Developments/Updates
o Key Strategies
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們